Heterologous neutralization breadth persists despite B-lymphocyte dysfunction in chronic HIV-1 infection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Heterologous neutralization breadth persists despite B-lymphocyte dysfunction in chronic HIV-1 infection ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Urheber
-
Murphy, MK
- Beteiligte Personen und Organisationen
-
Boliar, S.
Tran, TC
Carnathan, DG
Armstrong, WS
Silvestri, G.
Derdeyn, CA
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P103
- URN
-
urn:nbn:de:1111-2016080727363
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Murphy, MK
- Boliar, S.
- Tran, TC
- Carnathan, DG
- Armstrong, WS
- Silvestri, G.
- Derdeyn, CA
- SpringerLink (Online service)
Ähnliche Objekte (12)
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2
Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
Rational modification of an HIV-1 gp120 results in enhanced neutralization breadth when used as a DNA prime
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
P04-25. Exposure of HIV-1 pseudovirus to soluble CD4 increases the breadth of neutralization with sera from macaques immunized with recombinant glycoproteins
Patent Breadth in an International Setting
Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
The Neutralization of Egypt.
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2
Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
Rational modification of an HIV-1 gp120 results in enhanced neutralization breadth when used as a DNA prime
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
P04-25. Exposure of HIV-1 pseudovirus to soluble CD4 increases the breadth of neutralization with sera from macaques immunized with recombinant glycoproteins
Patent Breadth in an International Setting
Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
The Neutralization of Egypt.
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2
Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
Rational modification of an HIV-1 gp120 results in enhanced neutralization breadth when used as a DNA prime
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
P04-25. Exposure of HIV-1 pseudovirus to soluble CD4 increases the breadth of neutralization with sera from macaques immunized with recombinant glycoproteins
Patent Breadth in an International Setting
Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen